Physician

Matthew Charles Johnson, M.D.

According to 2025 Medicare claims, Matthew Johnson, M.D. (NPI: 1912133638) practices ophthalmology in the Elgin, IL market, with the plurality of this provider's patient population coming from De Kalb, IL. This provider's primary affiliated billing organization is DEKALB EYE CONSULTANTS, LLC (NPI: 1326380510; TIN: 237087041) and primary practice location at 60178-3103.

Johnson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 776 traditional Medicare patients, billed 3,024 HCPCS/CPT codes, and received $349,709 in Medicare payments. The top billing code was 66984 (Removal of cataract with insertion of prosthetic lens). Part D data shows 4,790 prescription claims across 899 beneficiaries totaling $346,692 in drug costs, led by Prolensa (Bromfenac Sodium). 2015 DME data shows 30 claims. Open Payments data shows 3 records totaling $219. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $204,723 to $346,692. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,223	4,376	$304,544
2016	955	5,231	$406,168
2017	1,052	5,554	$447,338
2018	1,054	4,737	$459,308
2019	967	5,300	$464,053
2020	893	4,081	$365,202
2021	984	3,819	$400,627
2022	862	3,535	$387,838
2023	884	3,388	$397,815
2024	776	3,024	$349,709

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	438	2,229	$204,723
2016	551	2,201	$230,087
2017	546	2,580	$298,628
2018	675	3,251	$338,377
2019	653	3,218	$328,985
2020	629	3,032	$314,296
2021	740	3,561	$378,234
2022	826	3,440	$418,524
2023	883	4,338	$411,070
2024	899	4,790	$346,692

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	30	30	$1,253
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
66984	Removal of cataract with insertion of prosthetic lens	273	460	$387
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	257	257	$100
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	311	329	$81
92133	Imaging of optic nerve	180	186	$23
92136	Measurement of corneal curvature and depth of eye	353	861	$17

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prolensa	Bromfenac Sodium	295	8,094	$102,251
Lumigan	Bimatoprost	92	4,382	$40,141
Bromfenac Sodium	Bromfenac Sodium	159	4,076	$35,417
Restasis	Cyclosporine	29	1,050	$22,828
Moxifloxacin	Moxifloxacin Hcl	1,016	15,411	$18,312

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$219	Harrow Eye, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Matthew Charles Johnson, M.D.?

Tedicare shows public-source Medicare data for Matthew Charles Johnson, M.D. (NPI 1912133638), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Matthew Charles Johnson, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Matthew Charles Johnson, M.D.?

Matthew Charles Johnson, M.D. is linked to DEKALB EYE CONSULTANTS, LLC (billing NPI 1326380510) in the available physician profile data.

Does Matthew Charles Johnson, M.D. have Open Payments data?

Matthew Charles Johnson, M.D. has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.